Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier

Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier

Chitosan is a natural polysaccharide, mainly derived from the shell of marine organisms. At present, chitosan has been widely used in the field of biomedicine due to its special characteristics of low toxicity, biocompatibility, biodegradation and low immunogenicity. Chitosan nanoparticles can be ea...

Full description

Bibliographic Details
Main Authors:	Xiaoyi Gao, Nan Liu, Zengming Wang, Jing Gao, Hui Zhang, Meng Li, Yimeng Du, Xiang Gao, Aiping Zheng
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	Molecules
Subjects:	chitosan nanoparticle vaccine carriers intranasal administrated vaccine/intranasal administration/intranasal vaccine design of experiment D-mannose
Online Access:	https://www.mdpi.com/1420-3049/27/1/204

Similar Items

Crosslinked Chitosan Nanoparticles with Muco-Adhesive Potential for Intranasal Delivery Applications
by: Mariacristina Gagliardi, et al.
Published: (2023-04-01)

Immunogenicity Evaluation of Recombinant Staphylococcus aureus Enterotoxin B (rSEB) and rSEB-loaded Chitosan Nanoparticles Following Nasal Administration
by: Seyed Amir Hosseini, et al.
Published: (2020-04-01)

Biodistribution and Adjuvant Effect of an Intranasal Vaccine Based on Chitosan Nanoparticles against Paracoccidioidomycosis
by: Samuel Rodrigues Dos Santos Júnior, et al.
Published: (2023-02-01)

Pre-clinical study of protective potency of candidate recombinant live pertussis vaccine for intranasal administration
by: L. N. Sinyashina, et al.
Published: (2019-08-01)

Crosslinked chitosan microparticles as a safe and efficient DNA carrier for intranasal vaccination against cutaneous leishmaniasis
by: Beatriz L.S. Costa Souza, et al.
Published: (2023-12-01)

Vaksin Pneumokokus Berbasis Protein (Pneumococcal Protein Vaccine: PPrV) Model Trivalent Terkonjugasi Adjuvan Aluminium dengan Administrasi Intranasal sebagai Metode Vaksinasi Terbaru untuk Pencegahan Pneumonia pada Balita
by: Eddy Zulfikar, et al.
Published: (2019-08-01)

Study of embryotoxic effects of intranasally administred desloratadine on laboratory animals.
by: Т. А. Alekhina, et al.
Published: (2017-04-01)

Intranasal Delivery of a Chitosan-Hydrogel Vaccine Generates Nasal Tissue Resident Memory CD8<sup>+</sup> T Cells That Are Protective against Influenza Virus Infection
by: James G. Bedford, et al.
Published: (2020-10-01)

Chitosan coating of anionic liposomes containing sumatriptan succinate: a candidate for nasal administration
by: Sara Assadpour, et al.
Published: (2021-04-01)

Between-strain differences in hypothermic response in mice after intranasal administration of PtO nanoparticles
by: D. V. Petrovskii, et al.
Published: (2015-12-01)

Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs
by: Santosh Dhakal, et al.
Published: (2018-05-01)

Systemic and Mucosal Antibody Responses to Soluble and Nanoparticle-Conjugated Antigens Administered Intranasally
by: Savannah E. Howe, et al.
Published: (2016-10-01)

Bordetella pertussis antigens encapsulated into N-trimethyl chitosan nanoparticulate systems as a novel intranasal pertussis vaccine
by: Hamid Najminejad, et al.
Published: (2019-12-01)

<i>In situ</i> gels as a modern method of intranasal vaccine delivery
by: Elena O. Bakhrushina, et al.
Published: (2022-11-01)

Intranasal Vaccination Strategy to Control the COVID-19 Pandemic from a Veterinary Medicine Perspective
by: Salleh Annas, et al.
Published: (2021-06-01)

Intranasal (IN) COVID-19 vaccines - a breakthrough
by: Ramandeep Singh Gambhir, et al.
Published: (2023-03-01)

A micro-sized vaccine based on recombinant Lactiplantibacillus plantarum fights against SARS-CoV-2 infection via intranasal immunization
by: Letian Li, et al.
Published: (2023-07-01)

Electrocardiogram Assessment in Chough (Pyrrhocorax pyrrhocorax) Following Intranasal Administration of Anesthetics
by: Majid Taati, et al.
Published: (2017-12-01)

Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2
by: Tuksin Jearanaiwitayakul, et al.
Published: (2021-07-01)

Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines
by: Hui Wu, et al.
Published: (2017-06-01)

Anesthesia and Sedation in Chough (Pyrrhocorax pyrrhocorax) Following Intranasal Administration of Diazepam, Midazolam, Xylazine with or without Ketamine: Clinical Evaluation
by: Abbas Raeisi, et al.
Published: (2016-12-01)

Intranasal delivery of RIG-I agonist drives pulmonary myeloid cell activation in mice
by: Nair, Sajith, et al.
Published: (2022)

mRNA Vaccines Encoding the HA Protein of Influenza A H1N1 Virus Delivered by Cationic Lipid Nanoparticles Induce Protective Immune Responses in Mice
by: Xinyu Zhuang, et al.
Published: (2020-03-01)

Intranasal midazolam alone versus midazolam/ketamine combination for preoperative sedation in pediatric patients undergoing ophthalmic procedures: a randomized controlled trial
by: Noha A. Osama, et al.
Published: (2022-01-01)

Immunity and Protective Efficacy of Mannose Conjugated Chitosan-Based Influenza Nanovaccine in Maternal Antibody Positive Pigs
by: Sankar Renu, et al.
Published: (2021-03-01)

Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice
by: Yu-Min Chuang, et al.
Published: (2018-02-01)

Clinical and pharmacokinetics overview of intranasal administration of fentanyl
by: Samaneh Nakhaee, et al.
Published: (2023-12-01)

Development of Different Methods for Preparing Acinetobacter baumannii Outer Membrane Vesicles Vaccine: Impact of Preparation Method on Protective Efficacy
by: Sun Li, et al.
Published: (2020-06-01)

Comparative pharmacodynamics of intranasal and enteral administration of captopril for uncomplicated hypertensive crises
by: I. L. Kechyn, et al.
Published: (2021-03-01)

A DNA Prime and MVA Boost Strategy Provides a Robust Immunity against Infectious Bronchitis Virus in Chickens
by: Shaswath S. Chandrasekar, et al.
Published: (2023-01-01)

Curcumin and Quercetin-Loaded Lipid Nanocarriers: Development of Omega-3 Mucoadhesive Nanoemulsions for Intranasal Administration
by: Gustavo Richter Vaz, et al.
Published: (2022-03-01)

Evaluation of Intranasal Midazolam for Pediatric Sedation during the Suturing of Traumatic Lacerations: A Systematic Review
by: Francisco Javier Gómez-Manzano, et al.
Published: (2022-04-01)

Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults
by: Felicia Scaggs Huang, et al.
Published: (2021-02-01)

Attitude towards Intranasal Vaccines and Psychological Determinants: Effects on the General Population in Northern Italy
by: Paola Boragno, et al.
Published: (2023-01-01)

Epitope-loaded nanoemulsion delivery system with ability of extending antigen release elicits potent Th1 response for intranasal vaccine against Helicobacter pylori
by: Yun Yang, et al.
Published: (2019-01-01)

Polymeric Nanoparticles as Oral and Intranasal Peptide Vaccine Delivery Systems: The Role of Shape and Conjugation
by: Prashamsa Koirala, et al.
Published: (2024-02-01)

Acceptability for the influenza virus vector COVID-19 vaccine for intranasal spray: A cross-sectional survey in Beijing, China
by: Yuan Ma, et al.
Published: (2023-08-01)

Comparative study between intranasal dexmedetomidine and intranasal ketamine as a premedication for anxiolysis and sedation before pediatric general anesthesia
by: Ahmed Elsayed Ahmed Mohamed Elshafeey, et al.
Published: (2020-10-01)

Non-Invasive Vaccines: Challenges in Formulation and Vaccine Adjuvants
by: Sumin Han, et al.
Published: (2023-08-01)

Inmunización intranasal de ratones con la proteína SAG2 de Toxoplasma gondii asociada con la toxina colérica
by: Jhon Carlos Castaño Osorio, et al.
Published: (2002-03-01)